Skip to main content
. Author manuscript; available in PMC: 2023 Feb 16.
Published in final edited form as: Mol Psychiatry. 2022 Jun 27;27(9):3658–3669. doi: 10.1038/s41380-022-01652-1

Fig. 4. Meta-analytical calculations comparing post-treatment and baseline blood levels of pro-inflammatory markers in responders and non-responders to ketamine.

Fig. 4

*Responder = participant with at least 50% improvement in depression scores. **The manuscript by Kang & Vasquez (2021) had only one non-responder, therefore, it was not possible to conduct meta-analytical calculations for the non-responder group in their study.